<SEC-DOCUMENT>0001193125-16-571158.txt : 20160502
<SEC-HEADER>0001193125-16-571158.hdr.sgml : 20160502
<ACCEPTANCE-DATETIME>20160502070703
ACCESSION NUMBER:		0001193125-16-571158
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160502
FILED AS OF DATE:		20160502
DATE AS OF CHANGE:		20160502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		161609707

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d190591d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of May, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Novogen
Limited </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>16-20 Edgeworth David Ave, Hornsby, NSW 2077, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form 20-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F&nbsp;&nbsp; <FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted
solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(7) only
permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is
not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#147;yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b) </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novogen Limited </B>(Registrant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Lionel Mateo </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lionel Mateo </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date 2 May 2016 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g190591tx_pg03a.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX:NRT</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NASDAQ:NVGN</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Ltd</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Company)</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABN 37 063 259 754</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Capital Structure</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary&nbsp;Shares&nbsp;on&nbsp;issue:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">429 M</P> <P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr John O&#146;Connor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Bryce Carmine</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deputy Chairman</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr James Garner</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Managing Director</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Ian Phillips MNZM</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Iain Ross</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr Steven Coffey</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prof Peter Gunning</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Non-Executive Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ASX RELEASE</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2&nbsp;May 2016</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOVOGEN PROVIDES UPDATE ON DEVELOPMENT OF CANTRIXIL</B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sydney, 2&nbsp;May 2016</B> &#150; US-Australian drug discovery company,
Novogen Limited (ASX:NRT; NASDAQ:NVGN) today provided an update on progress regarding the development of Cantrixil <FONT STYLE="white-space:nowrap">(TRXE-002-1),</FONT> its lead superbenzopyran (SBP) molecule, which is intended for the treatment of
ovarian cancer.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cantrixil remains on track to commence clinical trials in the second
half of 2016, as the Company has previously indicated. The proposed design of the phase I study has been amended in light of emerging data to focus more specifically on patients with ovarian cancer in order to better understand its effects in the
target population, and it is no longer anticipated to be restricted to patients with malignant ascites. It is envisaged that the study will be conducted at centres in Australia and the United States, and discussions are ongoing with potential
clinical investigators in both countries.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the international scope of the study,
Quintiles (NYSE: Q), a global clinical research organisation (CRO), has been engaged to support execution of the study. Novogen plans to submit an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) in
August 2016, and expects to achieve First Patient In (FPI) to the study in the fourth quarter of 2016.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparation for transition of Cantrixil into the clinic, Novogen has concluded funding to the CanTx joint venture with Yale University, and the CanTx entity
will be wound-up in an appropriate manner. All intellectual property licensed from Novogen to CanTx will be returned to Novogen, in accordance with the terms of the agreement between the two companies.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">CanTx was formed in November 2013 as a joint venture between Novogen, Yale University,
and certain of its faculty, with Novogen owning 85% of the company. The primary purpose of the joint venture was to facilitate the application of Yale&#146;s experimental models and preclinical test systems to Novogen&#146;s molecules. Novogen
licensed components of its intellectual property to CanTx for investigation in the laboratories of Professor Gil Mor, and this work has provided useful data to guide further development of Cantrixil, Novogen&#146;s lead superbenzopyran molecule, in
the field of ovarian cancer.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g190591tx_pg03b.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g190591tx_pg04.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A scientific review by Novogen&#146;s Board in August 2015 resolved to advance Cantrixil into clinical
development in this indication, and the Company&#146;s R&amp;D team have since been focused on designing and implementing an appropriate first-in-human study. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr James Garner, CEO of Novogen, said &#147;CanTx has been a helpful vehicle for performing some of the supportive experiments that have informed our
development of Cantrixil. As we move into clinical trials, a simpler arrangement will be advantageous and we will be returning the licensed intellectual property to Novogen&#146;s stewardship. We believe this represents the most appropriate use of
shareholder funds, and the most effective way to move Cantrixil forward.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the wind-up process, Novogen may be required to recognise an
impairment to certain inter-company loans between Novogen and CanTx, and these impairments will be appropriately reported once they have been fully determined. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr Garner added, &#147;we believe there is a strong basis to move Cantrixil into the clinic and the team has been working assiduously for some months on the
necessary preparations. We have completed most of the IND-enabling work, and are finalising protocol design in collaboration with external advisors and potential investigators, while also completing manufacture of the investigational product. Our
goal is to offer a meaningful new treatment option for patients with ovarian cancer, and we plan to give Cantrixil the best opportunity possible to demonstrate its potential in a clinical setting.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[ENDS] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About the Cantrixil (TRXE-002-1) drug
candidate </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cantrixil is a cyclodextrin-based formulation of the active ingredient, TRXE-002-1, which has shown <I>in vitro</I> and <I>in vivo</I>
anti-cancer activity in a range of tumor types. The Company anticipates that, if approved, the drug product would be used as an intra-peritoneal chemotherapy, either alone or in combination with other agents, and in one or more cancers of the
abdominal cavity (eg ovarian, uterine, colorectal and gastric carcinomas). A first-in-human clinical study is planned to commence in the second half of 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Novogen Limited </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen is an oncology-focused,
Australian-US drug development company, traded on both the Australian Securities Exchange (NRT) and on NASDAQ (NVGN). Novogen has two proprietary drug discovery platforms, the superbenzopyrans (SBPs) and the anti-tropomyosins (ATMs), which have
provided first-in-class agents with potential application across a range of oncology indications. The Company has three lead molecules Cantrixil, Anisina, and Trilexium, which are in advanced preclinical development for various cancer types, with
the most advanced molecule, Cantrixil, slated to enter clinical trials in the second half of 2016. For more information, please visit <U>www.novogen.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Enquiries </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kym Robins </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marketing and Communications Director, Novogen Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">E:
<U>kym.robins@novogen.com / </U>+61 (0)&nbsp;2 9472 4109 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g190591tx_pg04.jpg" ALT="LOGO">
 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g190591tx_pg04.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward Looking Statement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains &#147;forward-looking statements&#148; within the meaning of section 27A of the Securities Act of 1933 and section 21E of the
Securities Exchange Act of 1934. The Company has tried to identify such forward-looking statements by use of such words as &#147;expects,&#148; &#147;appear,&#148; &#147;intends,&#148; &#147;hopes,&#148; &#147;anticipates,&#148;
&#147;believes,&#148; &#147;could,&#148; &#147;should,&#148; &#147;would,&#148; &#147;may,&#148; &#147;target,&#148; &#147;evidences&#148; and &#147;estimates,&#148; and other similar expressions, but these words are not the exclusive means of
identifying such statements. Such statements include, but are not limited to any statements relating to the Company&#146;s drug development program, including, but not limited to the initiation, progress and outcomes of clinical trials of the
Company&#146;s drug development program, including, but not limited to Cantrixil, Anisina, Trilexium, and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks
and uncertainties relating to the difficulties or delays in financing, development, testing, regulatory approval, production and marketing of the Company&#146;s drug components, including, but not limited to, Cantrixil, Anisina, Trilexium, the
ability of the Company to procure additional future sources of financing, unexpected adverse side effects or inadequate therapeutic efficacy of the Company&#146;s drug compounds, including, but not limited to, Cantrixil, Anisina, Trilexium, that
could slow or prevent products coming to market, the uncertainty of patent protection for the Company&#146;s intellectual property or trade secrets, including, but not limited to, the intellectual property relating to Cantrixil, Anisina, Trilexium,
and other risks detailed from time to time in the filings the Company makes with Securities and Exchange Commission including its annual reports on Form 20-F and its reports on Form 6-K. Such statements are based on management&#146;s current
expectations, but actual results may differ materially due to various factions including those risks and uncertainties mentioned or referred to in this press release. Accordingly, you should not rely on those forward-looking statements as a
prediction of actual future results. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g190591tx_pg04.jpg" ALT="LOGO">
 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g190591tx_pg03a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g190591tx_pg03a.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T
M2%!H;W1O<VAO<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"
M24T$)0      $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1
M" "+ L8# 1$  A$! Q$!_\0 TP !  $$ P$!              4!!@<( @,$
M"0H! 0 !!0$! 0$            % 0,$!@<"" D*$  ! P," @4%"0L)!@8#
M 0 ! @,$  4&$0<A$C%!41,(87$B%!6AL<'1,D(C,PF!D6)RLG.S-#46-O!2
MDB1TM'6U=H+24V,7-^&B0T0E151D& H1  (! P("!@4(" 4#! ,!   ! A$#
M!"$%,1)!47$B$P9A@3(4!Y&AL<%",S0(T5)RLB-S%37PX6*"=*+")))#4Q;Q
M8[,7_]H # ,!  (1 Q$ /P#]Q96K4\>L]0[?-0%.=7;[@^*@'.KM]P?%0#G5
MV^X/BH!SJ[?<'Q4 YU=ON#XJ <ZNWW!\5 .=7;[@^*@'.KM]P?%0#G5V^X/B
MH!SJ[?<'Q4 YU=ON#XJ <ZNWW!\5 .=7;[@^*@'.KM]P?%0'DGJ)A2M3_P"B
MKWQ0%D4!8F2;@V.P=Y';<%SN2=4^J17!W;*N'ZU)!*&M#TI3S*\@K(M8URYJ
MURQ])$9V\XF&W;35R^OLKZV8"R',;WDCFDZ1W<-*^9FWQM6HK6G02GBMYP?S
MEDGLTJ3M6+=E=Q=[K-/S=QRLZ3=YTAT17!+Z7ZV6QS>?^D:O&!1]8YO/_2-!
M1]8YO/\ TC04?6.;S_TC04?6.;S_ -(T%'UCF\_](T%'UCF\_P#2-!1]8YO/
M_2-!1]9*VJ^72RR1+MDMV,]P"N57,VZD'7D>:(+;J->H@^2K=RW&['EEP,C'
MRLC$N>)CR<9_XZ'H9SQS=.W3^[BWUM-LEJT0):-3;WE=&J]=5Q%*/\XE/E%1
MUS#G'6WK$VS!\PV+O\/,_AW/UOLO]!E5"T.(2XVM#C:TA2'&U)6A:3T*0M)*
M5)/:*PVFG1\384U)<T6G%]*X'*A44 H!0"@% * 4 H"Z[(2(CFG_ !E?DM?'
M0$OSJ[?<'Q4 YU=ON#XJ <ZNWW!\5 .=7;[@^*@'.KM]P?%0#G5V^X/BH!SJ
M[?<'Q4 YU=ON#XJ <ZNWW!\5 .=7;[@^*@'.KM]P?%0#G5V^X/BH#BIWD25+
M4$I'22!U]0[2>R@(IZX*.J6=4CK4H>EKUE.OR=?OT!'<ZM22I1)))*CS'CY3
M0#G5V^X/BH!SJ[?<'Q4 YU=ON#XJ <ZNWW!\5 .=7;[@^*A5<33K*=#DV0$C
M_P"XN /'K]9<X^Y4[:^ZA^RCE^X\SW&]%.G\27TD%P[/=-7#%Y)_K?,8ZS#;
M''<Q[Q]QE=MO#GR+I  #CJN(2)D?4-S$^7T7-.A0K*QLR[C.BUM]3^H@-W\M
M8&Z-SDO#S7PG'C_N7"2_ZO28='A\RFWS"YD,IJ-9.\"6)L'G<D34J',$]R[I
M[/6=-#WNIU^2%5(/=;,XTM)NYU/_ !J:DO(FXV+M<V2CB-Z2C5RDNRG=]9ER
MR8Y9\=C"+:8:(Z2$]\\27),E2?GR'UDK<.O5P2.H"L"Y=N776;J;7A;?B;?;
M\+$@HQZ7TOM?23=6S-% * 4 H!0"@% 69DV"6'*$J<EM*B7#E"47.'HW)X#1
M(?3]7);'8H:Z=!%9%G)NV>&L>K_'20VY[)@[DG.\N7(II..C]?6O\*AKID^W
M^18SWCZVC<;8"2FXPTN*2A/49; 47(JNT\4?A5+V<NU=[M:3ZF:#N>Q9VW-W
M)Q\3'K[<=?\ U+BNW@6'WB^D'@>@ZKX_^>LDA*^@=XOM]U?^_0574.\7V^ZO
M_?H*KJ'>+[?=7_OT%5U$_C>-Y)E]R;M&-6F9>)[A&K,1MQ2&4$Z=]+?4M+$1
M@=:W%)2*M7K]K'ASWI*,3.V_;<_=<A8NW69WK[Z(K1+K;=(Q7I;1N]MOX4[7
M;@Q=-QI:;W- 2XC'(#SJ;/&5P4$3I8+;]Q4D]*$=VU^,*US+WN<ZV\5<L?UG
MQ]74=E\N_"_'QU')\P2\6[Q\&+[B_;EQGV*B]+-NXD.+ BL0H,=B'#BM)9C1
M8S2&([#*!HAMIIL)0A"1T "H)RE*3G-MR?%OB=5M6+5BW&S9C&%J*HE%))+T
M)%U6;ZA_\ZG\@U8N>UZC/QU1,G&W7&5A;:U(4.@I.GW".@CR&K9D$[&NX5HF
M0.17 =X">4]I4GJ)^\* F YS#5*@H'H*="#]T4!7G5V^X/BH!SJ[?<'Q4 !.
MAXGH[3VB@*'I/G/OT!2@% * 4 H!0"@% * 4 H!0"@% 6GEN563&[=*5<98$
MA3"NZ@,Z.S'CP(Y6@1W:2?G+*4^6KMNS<NONK3KZ#!S-QQ,&-;TN_3V5K)_H
M]9JADVX]ZO?>1XA]DVY14DLQG293R.H2)2>5?*>M*.5/GJ1LXD+?>EK(U#-W
MO+S$X0K;L/H7%KTLQR3K_+[Y/62:RR(J*H4% * 4 H!0"@% * 4 H"ZL>S&]
MXXXE,*1WD,GZ2WR27(BP>!*!J%L+(^<@@]NM6+N/;NKO:/K,_#W++P95LRK:
MZ8O5?Y>HS[CFX%DR#NXZW!;;DK0>IREI#;JM/_:R=$MN\>A)Y5^0U'7<:Y;U
MXQ]!M^#O6+F4A)\E[J?2_0R^JQR7% * 4 H!0"@% 759/U-S\\O\EJ@):@%
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MJD'5.O D<0=.H\* N*@% 5'0?-\(H >D^<^_0%* 4 H!0"@% * 4 H!0"@%
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M(GXE^3E+TL\%>BTM#R3OU20>QL_!50RRSTGSFJ I0"@% * 4 H!0"@% * 4
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M#J>;#K3C9Z%H4G[X.A^_50RR'6UM.*0L:*2H@CS=?F(H$==4 H!0"@% * 4
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M\Y+R?YLP\/!O9-EO%G9=RD[T.\[,_$E+6<%)VZ4;E%QUYE3[;US<^S!0"@%
M* 4 H!0"@% * 4!&7+H9\Z_>30$50"@% * \3GRU>>@.% * Q+<_VC/_ +9(
M_2JK,C[*[#6;_P")GVOZ3PUZ/(H"+OO[$NO]@E?HC5VS[7K,7-_!W?Y<OH9K
MW4J:(* 4 H!0"@% * 4 H!0"@% * 4!<>/Y9?,:<UM\GGC%96Y D<SL-W7Y7
MT>NK2S_.04JU[:LW+%NZM=&9^#N>9MTJX\NXWK%ZQ?JZ'Z51F;;;N?C5S9C,
M7&2Q8;A)D,1FH]P?;:C2I3@64-0YCA0VMQSD/*A92LD: &H^>'>A5Q3E%*NG
M0;AB>9-NR%&.1.-F_)T2DZ)MUHHMZ-NFBXE[_P OA]XUC$ZG4N*S?4/_ )U/
MY!JU<]KU&38X,F "HZ $D]0X^]5LR"6BVIQ9YI'T:.'H#BX>OS)^[QH"<:9:
M83R,H"$])ZR3VE1XF@.V@% 5'0?-\(H >D^<^_0%* 4 H!0"@% * 4!&7B\V
MG'[>_=KY<H5IML9)4]-GR$1V$Z GE25GF=<.G!" I2NH&O=NW.[+DMIN?4C'
MRLK&PK#R<NY"W8CQE)T7^;]"U-5K[XOL8@WCU2Q8U<K[9VW>21=W92+6\\ K
ME<<MUO=CO+<;XZI+RFBK3H J5ALUV4*SFHSZOTLY[E_$K M9*AB8\[V*GK-O
ME;_933]56J^@S]ANY.';B6QZ5B]V:E/HC.*EVI_EC7> 2TK42H"U=YR))T[Q
MOG:/4JL"_BWL:5+J=*\>A^LW':]]VS>\=W,"XG+EU@^[..G3%ZZ=?!]!JYV^
M<^^:ET:)T+L%"@H!0"@'D[>F@(J7:V7]5M?1+/9\@^=/0/.*J49;DB*]&5RN
MI(&I 6 2A7 D:*'#B!YZ%:GGJ@% * 4 H!0"@% * 4 H!0"@% ;2;9_P;;?S
M]P_OCM1&7]_+U?0;_L7]JA^U+]YF0F677UAMI"EK/4D='E)X!*1UDUC$L8O\
M0^[.*^&S9#<#>?.5-28.)61]=NLG.E)R3);D/9^-XRR5_7N7N[/MM+ X)8[Q
M9U2E52>S[9>WG<K6VV/:N2U?0HK64GV+YVD:9\0O.^W_  Y\G9WG'<I4MXEJ
MMN*=)7;\M+-J&J?-.XUJM8I.70?EWC_:T>)**\Q*B[<>%J*_&>;DQQ'V%QQD
MQW67 \R&)34E$AHLJ2 EQ)2M)',"#78E\,?*R]F%ZJZ5*/'K]CZ#\[Y?GE_,
M#.+5S.Q'"5:Q<+S33XI_^1JFM'5:HUS\8JG<NW-:\1$2Z7"\XCXFH3VY]CN-
MUDF5-LN1!UNT;@[:7"4H)3Z]MODT94)A&B2JT*@N@<K@-;+Y>Y;&'_2)1C'(
MPWX;2X./M6YKT3CJ^J:DN@XA\67+=/,:\_6KD[VU>8XO,MSDU)V[M?#RL232
M24L2\G;BJ+^ [,Z4D6QX6,:%YW;M6:S[[<L6PK9)E.]&X>865_U>Z6'&<&FQ
M)T:)997%+>39=D"H=FM:.)7-G).A2E57M\OJW@RQE&,\G)_A0B]5*4DZMK]6
M$:SD^A)D?\,]N]Z\TVMZOW[F+LVS+^H961;=)VK.-)34;<NB]?N\EBRNFY<3
MHTF;WW'[;7QGRY]PDV^-M!;(4F9+?@6YS 7)R[?$??<7#@N3%7Q"YKD-A:6U
M.D)+I25$#6M7A\-?+L8)3>0YI*KYZ5?2Z4T3XI5.X9'YS/C!.[<N6([3;LN4
MG&#Q7-QBVW&/-XJYG%47-15:KH?:RS>.&X;E?9RY[XKMO%V&W[H8-MU=U7ZT
M3X)N=EQO=''50(US8FV@R6GI%EE^MHFQFE.I*XLA YM4DUR/S#L]S8MUN8,Z
M^#7FMM],'K'UK52]*])^@OP@^(V'\4O(F'YIL<D<]IVLJW'_ -K)MT5R-'JH
MRJKENOV)K5T9DO8?Q&YYG/A[WFG;AQ+#9?$CX=(6XF,[JV6VPUM8\K+\9Q6?
MEN&9A9[8Z^ITX;N!C3D&YPTEPA3;CC?-J@Z0CI70Z:6E \3F\><X/X3,!VNM
MF#S?$3XBMC;+O5F&4Y7 N7_3;:?!(MEQ]659W<,9L\V/=+Y*NF47YJW6*S-R
MXZ'Y!6IU]+3*M:I*C;Z =6Y&>>*_PE0+=N]NMN7@/B+V#@9!8;=O''M6U3&T
MVXVU^-Y#>(5C_P"HN)/V?)LALN68]C,^X-.7*WS6VY0AE3C3RBA0JG%T0,R^
M$[>3,]T[;O#ANZ*[*YNSL5OAFNUF6+QZW^RK7>+!WS.2;799 MO?2>XCY5M]
M>83VH6I#CR'%)X<!33H!KC(\9^Z=SRO=VV;<8WBF9O9-XEF?"AX3,>N29-IM
M-XRW;[$7;WO]NMN%D\)R1/E;>X-/:E M1&DO*]0]7;5WCX4FM.L%];AI\>FR
M>(7K>!O=;:/Q#P\+MDK*,YV/B;,.;7R+QB]HCKN&31MJ\YA9CD5T:R6W6MAY
MZWLWAF0U.6T&UJ0M8JO=?6"0O7B5W WOS# ]LO"#(PB([DVSF'[^9YO)N3:+
MID6/[;;=[BEU&W=EM6$6>YV9_*=QLQ,.6ZB/(G1H4&)$6ZZI94A)\]H,M8I9
M?$?MW9MQ[[NGO=@N[=KM>!7^\8JS:=F&=M;W:<EL]KGW)+USE6[,K_:[Q8W&
MXR4]QW#+X5J2X1P-= 8G\,3_ (O-VMK-B-[LOW_VY]A;BX9@VX>1X+:_#HQ
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M]1XC,8?1IU7UN*T*_N'YH\U81LQZ: 4 H!0%1T'S?"* 'I/G/OT!2@% * 4
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M*'8?@/2* C'X"AZ3*N8:?5J^4/Q2>!H"-*5 D$$$=((XB@*4!XG/EJ\] <*
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M?/U'IH5JZ4Z"BEK6-%*) .NA/#7S=%"GH.- * 4 H!0"@% * 4 H!0"@% *
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M&YEIP5NSS,;SK(VK1!NV8Y?CS=P3AV-M)SJZ7=J!C;;B[>VA+Z'G7$J2 V0
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M&[G:+'N_L#;;[OW*N5V3E7AR9O\ $M#3.5V&P69]B1=H-Y]45'FNJ)3&Y&@
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M/?:6E ^S)W**O11^XFS'\T:#][< Y0.;1.IZJYYY-T\Y6F^/BWG_ -,SZ_\
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M ]G;0$?0"@% * 4 H!0%%?(7^(O\DU5<2CX/L,(GI-9AK!2J@4 H!0"@% *
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%X10'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g190591tx_pg03b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g190591tx_pg03b.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T
M2%!H;W1O<VAO<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"
M24T$)0      $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1
M"  Z L8# 1$  A$! Q$!_\0 S@ !  $$ P$!              4#! 8' 0((
M"0H! 0 " P$! 0             $!0$#!@('"!   0," 04)"0P' PP#
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M6UCTI<_Q*X_?JK[5-V.I#XM7WI;6/2ES_$KC]^JOM4W8ZD/BU?>EM8]*7/\
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MKFX>->I.?:WALT$!7#_X=1@/W9R ;@()R!>S1AD86L ( @" ( @" ( @" (
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M7NR\#1H]] 2,5FIF8&1SYCO'X#,G TEQQXT!+-:UC0UH#6M  :   !O (#E
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M'.K*4GU9+VLX*^_N7S*KC'E]"E2CKFW.7_+'P9HW:+MB[3MJ=-MWVTO75WC
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M>HPLXDEQ)<XYW$DN/&3B2I*262*K#/'I.$ 0! $ 0! $ 0! $ 0! $ 0! $
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M=TS2Z$6'#BO$JM.'$T2:-G=U\Z5.;6O#!;7D972]F]\F;I5$]!1?(?))4/\
M=U#"P?.*CRO:2X4V65/D-Y+.I*G!=K;\,O$XJNSB^PC&FFH:XG,QDCX)"=YK
M9V!CC^L$C>TGQ)H5.0WL5_E.$WVM/Q^DUEM[V,=INVUHI[-L]LK53UC+K3U#
MWUE116VC9!'#4L=,:VNJ(8'L#I!R"YQQR!3K3F%I;U'.K-;N[T9O8CFN?^E?
M4'-;6-I96TW555-[SC&.&[)8[TFELQ94V2_(;MC62PR[;[8V*P4I(,U%8(JB
M^W/1R$QMJ*B.WVV%Y&(TL9@-XKW6]14(K"A"4I:WDO:_(C<M_L_S2K)3YK=4
MJ-/I5-.I/:U&*[?K=A]!^SKLYV5[+=F:;979*B?34$,CZFJJ*F37W"Z7"5K&
MSW"XU.BS75,HC  :UK(V -8T-&"YFZNJUY5=:L\9/HZ$M21]IY)R/EWI^PCR
M[EL'&BGBVWC*<GIE)]+?<DLDDC.E'+<( @" (#LW,_Q1]-J ZH @" Z/D9&,
M7N#<<V^>(#*4!:NKF#D,<[C.B.]B4!;.K)G8X:+!\D8GNNQ0%!SWOY3G.XR2
M.YF0'1 $!PX![2QX#V'.QX#F'C:X%I31FM)AI-;KSB^@@9ME=F:B;K$UAM4D
MV..F:.)N)&ZYK UCCCO@K:JU9+!2>!$ERZPG+?E1IN7\*)>.GIZ2GDBI:>"E
MC$4@$=-#' S#0=DT8FL"\8MR3>;Q)"IPI4W"G%1CAH22\C3!_P NZ5,.<9PA
M@( @" ( @" ( @" HRTU/.,)H(9>%\;2?G8:7?7I3DM#-<Z5*IQQB^XBYK!0
M28ZL2P..ZQ^FW'Q)-+)[H6Q7$UIP9#GRVWEG#>B^IXK8R)FV=J&Y8)HIAO/!
MB=_;;WPML;B+XLF1)\LK)?Y<HR[<O\"%J*6HI'Z%1$Z,G'1)P+7 ;K7 EKNZ
MMT9*7#F0:E*I1>[533_;I*"R:P@" (#AQ#&E[R&,&=[R&L'&YQ#0LAM+-Y(-
M(<T/:0YAS/:0YIXG-):5@)IK%:#E >I^S7V,M7CU_P#7U*J+OY[[O([[D7Z7
M3_F^](SI1BW" ( @" ( @" ( @" ( @" ( @" ( @" Z2RQ4\;IJB6*GA:"7
M33R,AB:!G+I)7-8,.-$F\EFS$I1A'>FU&.MY+Q->7CM<[/+$]T=5M+25=0PD
M&EM+9;K.7 8Z(-&R2G#N-X"E0LKJIFH-+6\O,I+GU)R2T;C4KQE-=$,9O_AR
M\3%ZKM/I)@)K;:ZA[*AC9XGU[VTIT)AK&:5/'K7@X.RC2&595J\<)-=QXESZ
MG*"G0IR:DDUO9:5CHS?<8Q5;=[15!.KJ(*-NXVEIHP1_M)M<_OK8K>DM*Q[2
M#4YO>ST-174OIQ+./;#:6-VEZ5FDRXZ,L=/(T\!:Z',O3HTGE@:US.^3Q^(W
MVI?09!1]H]QBP;745+5MR8OA+Z67CP_:Q.)X@M;MH/A;1,I<[K1RK0C):UD_
M:C*Z/;^PU&B*@U5 \YQ-"98P?[V OR<8"TNWJ+1@RPI<XLY\>]!]:Q6U8F30
MUUJNT6A#4T-PA>#C"7PS@C,0ZGDQ/=:M3C.#QP:9/C5M[B.$90G%]&3\&8M=
M>S38B[Z1J+!34LSCI=8MA?;9L<,,2*8LA=^LPA;H7=Q#1)M=>97W'(N57/'1
MC&6N/U7X9>!K>Z]@M%(7/LE_J:;)\&"YTS*I@.]UFF=3R <<;BI<.92_$BGV
M%%<>CZ3SM*TH]4TFMJP?@S6]S[(-N;<7.BM]/=8FXX26NKBE>0#D/5JCJ]1E
M&X&E2H7UO+2VGUHHZ_IKF]#AIJI'7!I^#P?@:\K;?<+9(8KC0UE!("065E+/
M3'$9#AKF,!R[V128SC-8Q::*:K1K4);M>$H2_>37F6:]&H( @" ( @)"@M5R
MNCW,M]%459;AINB9^S9CFUDKBV)A.\3BO$ZD*:QFTD;Z%M<7+W:$)2:U:-N@
MS"C[.+Y/@ZKEHZ!ARD.D-3-Q:N$:L$^.H\KVDN'%LM*/(KR>=5PIKMQ>Q9>)
MEM%V;6>'#KM565S\Y:US*2+BT8M*4_/4>5[4>44D6=+D%K#YLIU'_2O#%^)G
M5LV1HZ8--OL4$9& U[Z=I><PTM?4Z4AXP5&G7J2XY-ES;\KI4\/@48QZ\,]K
MS,KBV>JGY9YX80-QFE,[#>&&@P=TK1OKH+*-C4?S))>))PV"ACPUAEG(./PW
M:#3P:,>&3C)7ES;T$F%E1CQ8R9*14U/ ,(8(H^%C&AWSL-(]U>6V])(C3IPX
M4D73.4>+P+![+ME3/'R)7@#<+B6_-.(0%ZRZ3CEMC?Q#0/>Q'>0%ZRYT[N4'
MQGA;I#NMQ/>0%Y'+%*,8WM?AGT2"1QC.$!40! $!V;F?XH^FU =4 0'(SCCW
M<WNH")JN=?GY+>5Q_%^2@+1 $ 0! $ 0! <.Y+^3R'\KD\D\KY.^LK28EPOL
M-*NY1YKE.S9N4>3\G>X%-.9>DXZ-# Z- .C0#HT Z- .C0#HT Z- .C0#HT
MZ- .C0#HT!"[0>KCS'/1<OE9SS/R]_@Q6ZAQE?S+\MT<2[>XPCHU,*(=&@'1
MH"A4<Q-SG-N\T\YS?N/XF]PK*[N\\RT/3HZ-/=UGCWM.\YD]ON=/M3ZKW/-?
M[/ KNUT+Y?\ +I/G_.>-_FO^[PZ"IV7><M]O^7_^9]4<G_B>'?7F[T/Y7\VD
MSR3YB_-:?PN#O/7T'-1<OFV><<__ +;^+^DJ>7=W'?1T+3HZ?:>L^S_V.LOF
M_-3>;\CSJ?E_Q_*?+Q5)<_/EI/H?)?TVGP].C1I?CKZ\3,5H+4( @" ( @"
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g190591tx_pg04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g190591tx_pg04.jpg
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M+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T
M2%!H;W1O<VAO<" S+C  .$))300$       /' %:  ,;)4<< @   @ " #A"
M24T$)0      $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4 9,     !_]L
MA  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1
M"  ^ L8# 1$  A$! Q$!_\0 R@ !  $% 0$! 0            4! P0&!P@"
M"0H! 0 " P$! 0             $!0$#!@('"!   0,#  8' 0D+"P('
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M+6X8)(9HS5CV'I'2"#H(.D'0=*@RBXO=EHT=):NV[UM7;34K<EHT9"P>P@"
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M<)(*F*9KM@>TM-.T;PJLC4CY<?=Q:3"]PVL >/FDE8!AD$&A!!'000>XH"B
M( @" ( @" ( @" ( @" (#U-Z:?P;C?IK_\ U<GFJC+_ %$O0=[P'^60ZY?B
MD;VHQ<&3%9W4WZN"0C:1N-_&?NM0$C%A)W?K98X^H5D/@ /% 2,6'M(R"\R3
M$4-'G=;HZ"UNDCW4!*-:UH#6@-:T4  H !T #4@*H @" ( @" ( @" ( @"
MC,EJA[7^\U 12 ( @" P7_'=_./OH#Y0!#*VG)<E_N%]_G+C^T<I<?"NHYF_
M^IG]Y^LP5[/ 0$1G_P#8\M_D)_R5LM?F1^\0\_\ 17O]MGGY6QPP0! $ 0!
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M?AD>7*5T'2#T*Y/FA^I'V!P!R!SZ  !_S.ST 4'^PVW0N0\Q_J+?W/\ ,S]
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M_24F1PWB&+^HLW(KGI5=JJN\URH-=.K7U=NQ;2%4( @" ( @" ( @" ( @"
M^FM<]P8QKGO.IC&E[SV-:"XHVDJO892<G2*;?0;#9<I<Q7X:Z'%SQQNTB6Z+
M;1E-M)RR0CL:5IED68;9+T:DZSPS/O>&VTN>7NKO-KM/3*^>VM]D[:V=3]7;
MPR7)!ZY'N@9JV J/+.BO#%LL;7E^\];UR,>A)OOT*W/IAD:?^G9""\?T0RV\
MT#SJJ ^(W#:]H"1SH_7BTCU/R[??Z>Y&3YFFO54Y]SOZ >I?.^)APV*QV-M)
MFY.UNGW67R]K8V;8(HKAKWA[>/</(,@HT1%QV*;B\3Q,>X[DVVMU[%5G/\;\
ME^8.+8L<3&MPC)7$]Z<THTI)<E7W$CRG]@AH?;W'//J"V6(%CY\9REC7,+QN
MU=",SEG'=&]HWVVAJ-5%F]YCT:Q[>O/)^Q?2:N'?T=I)3XOFUCRPLQIZ-^?K
M4#W;R3R/ROZ=\O6G*_*&*BQ6(M'/DX;7/FN;JYEIQKV_NY2Z>\O)RT;SWG4
M  T #G<C(O95UWK\JS?9Z%R'U[A7".'\$PH\/X9;5O&CR;6V]LI-ZRD^5OT4
M6AMBTED$ 0! $!4:CV?=" '6>T^^@*( @+4DT<0&^=)U-&EQUZ:= T=* Q'7
MWR(_=<?N#S0&.ZZF=]]NC8T;OCK0%@N+M+B2=I)/OH"B ("H)&HD=B P)L9C
M+F43W&.L)YQ2DTUE;2RZ-7Z1\3G&G:O2G-*B;IUFF6/CSEOSMP<^=Q3?J,Q^
MB*1HT-$4@#0*- #'4 :*  +$?$NLVO2-%LH<14PYA[0L@( @" ( @" ( @"
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M+CX:$PF8@UK.XO%>CX(#6:.Q8<V^@D0Q+$.2KZ238QD3=V-C(VC[UC6L'<T
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32 4&T>/D@*@"ATC5U[1U(#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
